American Well Corporation reports developments for Amwell, a SaaS-based software platform for technology-enabled healthcare used by payers and health systems. Company updates center on quarterly and annual operating results, business reviews, investor conference participation, and equity-compensation actions such as inducement-plan grants.
The Amwell platform combines software and services that support virtual care programs across the care continuum, including virtual primary care, urgent care, clinical partner programs, scheduling, provider workflows, prescribing, and treatment-guideline reference tools. News about AMWL commonly connects these platform capabilities with payer and health system relationships, partner clinical programs, and management commentary on technology-enabled care delivery.
Amwell, a telehealth leader, announced the pricing of its upsized IPO at $18.00 per share, raising approximately $742 million before expenses. The offering includes 41,222,222 shares, with an additional 30-day option for underwriters to purchase up to 6,183,333 shares. Shares will start trading on the NYSE under the symbol 'AMWL' on September 17, 2020, and the offering is expected to close on September 21, 2020. The SEC declared the registration statement effective on September 16, 2020.